Stay updated with breaking news from India Based Glenmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. branches of Teva and Glenmark will pay $225 million and $30 million, respectively, to settle what Politico notes are "long-running criminal price-fixing charges." Separately, Boehringer Ingelheim, a German drugmaker, is suing the U.S. government over its Medicare drug price negotiation effort.
Two major generic drug companies Monday settled charges of criminal price fixing with the Department of Justice (DOJ). The U.S. division of Israel-based Teva will pay a $225 million criminal penalty over five years, and the U.S. division of India-based Glenmark will pay a $30 million criminal penalty, the DOJ announced. The two companies entered…
The settlements resolve a criminal probe of the generic pharmaceutical industry dating to 2014.
Some consumer health advocates and pharmacists are concerned that the FDA and the FTC aren’t doing enough to monitor where more and more people see ads.
The settlements resolve a long-running criminal probe of the generic pharmaceutical industry dating to 2014.